New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk

February 2003

New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk.

Traditional CRP tests are useful to diagnose rheumatoid arthritis, lupus, and other inflammatory diseases.

Now high-sensitivity CRP (hs-CRP) tests are recommended by the American Heart Assoc and CDC to help predict cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote